[Use of prodigiozan and zymosan in treating children with viral hepatitis A].
Lebenzon
S S
SS
Maianskiĭ
D N
DN
Gavrilova
N I
NI
Kutina
S N
SN
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D003289:Convalescence; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D006506:Hepatitis A / Q000188:drug therapy* / Q000276:immunology / Q000503:physiopathology; D006521:Hepatitis, Chronic / Q000517:prevention & control; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D007223:Infant; D008099:Liver / Q000187:drug effects / Q000503:physiopathology; D011135:Polysaccharides, Bacterial / Q000627:therapeutic use*; D011354:Prodigiozan / Q000627:therapeutic use*; D015054:Zymosan / Q000627:therapeutic use*
D011135:Polysaccharides, Bacterial; D015054:Zymosan; D011354:Prodigiozan
Primenenie prodigiozana i zimozana pri lechenii deteĭ, bol'nykh virusnym gepatitom A.